Welcome to our dedicated page for Genpact SEC filings (Ticker: G), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Genpact Limited filings document the disclosures of a Bermuda-based operating company listed on the NYSE and focused on agentic and advanced technology solutions. Its 8-K reports furnish quarterly and annual results, include non-GAAP reconciliations, and describe operating categories such as Advanced Technology Solutions and Core Business Services.
Genpact's proxy and annual meeting filings cover board elections, executive compensation votes, auditor matters and shareholder voting results. Other filings document material agreements and capital structure, including senior unsecured notes issued by indirect wholly owned subsidiaries and guaranteed within the Genpact group, as well as officer appointments and related governance disclosures.
Gangestad Nicholas C reported acquisition or exercise transactions in this Form 4 filing.
Genpact LTD director Nicholas C. Gangestad received an equity grant in the form of restricted share units. He was awarded 6,521 unvested RSUs, each representing one common share at a future date, increasing his direct holdings to 15,334 common shares after the award.
The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Subject to his continued service, the entire RSU award will vest on December 31, 2026 and will be settled in common shares on December 31, 2027, aligning his compensation further with long-term shareholder interests.
Subaiya Thimaya K. reported acquisition or exercise transactions in this Form 4 filing.
Genpact LTD director Subaiya Thimaya K. received a compensation grant of 6,521 unvested restricted share units (RSUs) of common shares at no cash cost. Each RSU represents one future Genpact common share. Subject to continued service, all RSUs will vest on December 31, 2026 and be settled in common shares on December 31, 2027. Following this award, the director holds 8,541 common shares directly, including the unvested RSUs reported in this filing.
Verdi Mark A reported acquisition or exercise transactions in this Form 4 filing.
Genpact LTD director Mark A. Verdi reported a compensation-related share grant. He received 6,521 unvested restricted share units (RSUs), with each RSU representing one common share granted at no cash cost. These RSUs fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027. Following this award, Verdi directly holds 71,526 common shares.
Genpact Limited director Brian Mark Stevens received an equity award in the form of restricted share units. He acquired 6,521 common shares at a price of $0.00 per share through a grant classified as a non-derivative award. Following this award, his direct holdings increased to 36,619 common shares.
The grant represents unvested restricted share units (RSUs) under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles him to one common share. Subject to his continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.
Conigliaro Laura reported acquisition or exercise transactions in this Form 4 filing.
Genpact LTD director Laura Conigliaro received an equity award of 6,521 unvested restricted share units (RSUs). The grant was made in the form of common share RSUs under the Genpact Limited 2017 Omnibus Incentive Compensation Plan as part of her director compensation.
Each RSU entitles her to receive one common share at a future date. The RSUs are scheduled to fully vest on December 31, 2026, assuming she continues in service, and will be settled in common shares on December 31, 2027. Following this grant, she directly holds 79,337 common shares.
Madden James C. reported acquisition or exercise transactions in this Form 4 filing.
Genpact LTD director James C. Madden received an equity award of 9,999 restricted share units (RSUs) of common shares. The award was granted at no cash cost per unit and increases his directly held common share interest to 73,067 shares.
Each RSU represents the right to receive one common share in the future. Subject to his continued service, all RSUs will fully vest on December 31, 2026, and will be settled in common shares on December 31, 2027, under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
Genpact Ltd: 03/13/2026 amendment shows The Vanguard Group reports 0 shares beneficially owned and 0% of Common Stock. The filing explains an internal realignment effective 01/12/2026 that led certain Vanguard subsidiaries to report ownership separately.
The statement lists no voting or dispositive power for Vanguard over Genpact common shares and affirms no single other person holds more than 5% of the class according to the report.
Genpact LTD Chief Financial Officer Michael Hal Weiner reported a tax-related share disposition linked to equity compensation. On the vesting of performance share units granted on March 15, 2023, 7,019 common shares were withheld at $38.92 per share to cover tax obligations. Following this non-market transaction, he holds 181,874 common shares directly.
Genpact Limited Senior Vice President Riju Vashisht reported a tax-related share disposition. On this Form 4, 7,080 common shares were withheld at $38.92 per share to cover taxes due upon vesting of performance share units granted on March 15, 2023. After this withholding, Vashisht directly holds 123,668 Genpact common shares.
Genpact LTD Senior Vice President Anil Nanduru reported a routine tax-withholding transaction related to equity compensation. On this Form 4, 7,663 common shares were withheld at a price of $38.92 per share to cover taxes due upon the vesting of performance share units granted on March 15, 2023 under Genpact’s 2017 Omnibus Incentive Compensation Plan. After this non-market disposition, Nanduru directly holds 105,539 common shares, indicating the filing reflects compensation-related tax settlement rather than an open-market sale.